905 related articles for article (PubMed ID: 16958699)
21. Platelets possess functional TGF-beta receptors and Smad2 protein.
Lev PR; Salim JP; Marta RF; Osorio MJ; Goette NP; Molinas FC
Platelets; 2007 Feb; 18(1):35-42. PubMed ID: 17365852
[TBL] [Abstract][Full Text] [Related]
22. In vitro capacity of different grades of chitosan derivatives to induce platelet adhesion and aggregation.
Periayah MH; Halim AS; Hussein AR; Saad AZ; Rashid AH; Noorsal K
Int J Biol Macromol; 2013 Jan; 52():244-9. PubMed ID: 23063426
[TBL] [Abstract][Full Text] [Related]
23. Reduced GPIIb/IIIa expression in platelets hyposensitive to catecholamines when activated with TRAP.
Kim JM; Koo YK; Heo JE; Park S; Yun-Choi HS
Thromb Res; 2009 May; 124(1):90-5. PubMed ID: 19232685
[TBL] [Abstract][Full Text] [Related]
24. Transmission and scanning electron microscopy of N2 microbubble-activated human platelets in vitro.
Thorsen T; Dalen H; Bjerkvig R; Holmsen H
Undersea Biomed Res; 1987 Jan; 14(1):45-58. PubMed ID: 3810992
[TBL] [Abstract][Full Text] [Related]
25. Modulation of platelet activation and initial cytokine release by alloplastic bone substitute materials.
Klein MO; Kämmerer PW; Scholz T; Moergel M; Kirchmaier CM; Al-Nawas B
Clin Oral Implants Res; 2010 Mar; 21(3):336-45. PubMed ID: 20074241
[TBL] [Abstract][Full Text] [Related]
26. Preliminary separation of the growth factors in platelet-rich plasma: effects on the proliferation of human marrow-derived mesenchymal stem cells.
Huang Q; Wang YD; Wu T; Jiang S; Hu YL; Pei GX
Chin Med J (Engl); 2009 Jan; 122(1):83-7. PubMed ID: 19187622
[TBL] [Abstract][Full Text] [Related]
27. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system.
Weibrich G; Kleis WK; Hafner G
Int J Oral Maxillofac Implants; 2002; 17(2):184-90. PubMed ID: 11958400
[TBL] [Abstract][Full Text] [Related]
28. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation.
Everts PA; Hoffmann J; Weibrich G; Mahoney CB; Schönberger JP; van Zundert A; Knape JT
Transfus Med; 2006 Oct; 16(5):363-8. PubMed ID: 16999760
[TBL] [Abstract][Full Text] [Related]
29. Use of a Cyclooxygenase-2 Inhibitor Does Not Inhibit Platelet Activation or Growth Factor Release From Platelet-Rich Plasma.
Ludwig HC; Birdwhistell KE; Brainard BM; Franklin SP
Am J Sports Med; 2017 Dec; 45(14):3351-3357. PubMed ID: 28952781
[TBL] [Abstract][Full Text] [Related]
30. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
31. Role of platelets in atherothrombosis.
Jennings LK
Am J Cardiol; 2009 Feb; 103(3 Suppl):4A-10A. PubMed ID: 19166707
[TBL] [Abstract][Full Text] [Related]
32. Time- and pH-dependent release of PDGF and TGF-beta from platelets in vitro.
Liu Y; Kalén A; Risto O; Wahlström O
Platelets; 2003 Jun; 14(4):233-7. PubMed ID: 12850832
[TBL] [Abstract][Full Text] [Related]
33. Effects of Aspirin on Growth Factor Release From Freshly Isolated Leukocyte-Rich Platelet-Rich Plasma in Healthy Men: A Prospective Fixed-Sequence Controlled Laboratory Study.
Jayaram P; Yeh P; Patel SJ; Cela R; Shybut TB; Grol MW; Lee BH
Am J Sports Med; 2019 Apr; 47(5):1223-1229. PubMed ID: 30888847
[TBL] [Abstract][Full Text] [Related]
34. [Construction and characterization of bispecific single-chain antibody fragments SZ-2/SZ-21 against platelet glycoprotein Ib alpha and beta3].
Dai K; An G; Ruan C
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1493-7. PubMed ID: 12509914
[TBL] [Abstract][Full Text] [Related]
35. Counting of platelet derived growth factor and transforming growth factor-beta in platelet-rich-plasma used in jaw bone regeneration.
Tonelli P; Mannelli D; Brancato L; Cinotti S; Morfini M
Minerva Stomatol; 2005; 54(1-2):23-34. PubMed ID: 15902060
[TBL] [Abstract][Full Text] [Related]
36. Glycoprotein Ibalpha-mediated platelet adhesion and aggregation to immobilized thrombin under conditions of flow.
Weeterings C; Adelmeijer J; Myles T; de Groot PG; Lisman T
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):670-5. PubMed ID: 16357309
[TBL] [Abstract][Full Text] [Related]
37. Adhesion, spreading, and aggregation of platelets in flowing blood and the reliability of the retention test Homburg.
Krischek B; Morgenstern E; Mestres P; Klinkhardt U; Brannath W; Wieding U; Nemeh A; Heinrich W; Schenk J; Wenzel T; Wenzel E
Semin Thromb Hemost; 2005; 31(4):449-57. PubMed ID: 16149023
[TBL] [Abstract][Full Text] [Related]
38. Chitosan inhibits platelet-mediated clot retraction, increases platelet-derived growth factor release, and increases residence time and bioactivity of platelet-rich plasma in vivo.
Deprés-Tremblay G; Chevrier A; Tran-Khanh N; Nelea M; Buschmann MD
Biomed Mater; 2017 Nov; 13(1):015005. PubMed ID: 29125132
[TBL] [Abstract][Full Text] [Related]
39. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
Viisoreanu D; Gear A
Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
